| Joshua F Phillips, MD | |
|
1513 Lakeland Dr.,, Suite 101, Jackson, MS 39216 | |
| (601) 354-4836 | |
| (601) 354-2619 |
| Full Name | Joshua F Phillips |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 22 Years |
| Location | 1513 Lakeland Dr.,, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407955537 | NPI | - | NPPES |
| PENDING | Medicaid | MS | |
| 03053368 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 18672 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mississippi Asthma And Allergy Clinic Pa | 7416993522 | 12 |
News Archive
Biostar Pharmaceuticals, Inc., a PRC based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial results of the third quarter ended September 30, 2013.
MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners.
A new study conducted by researchers from Tulane University finds reducing target systolic blood pressure below current recommendations significantly reduces the risk of cardiovascular disease and preventable death.
Discovering key elements of immune system T cell biology and applying that knowledge to create a new way to treat cancer has earned Jim Allison, Ph.D., the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.
› Verified 3 days ago
| Entity Name | Mississippi Asthma & Allergy Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902882251 PECOS PAC ID: 7416993522 Enrollment ID: O20050629000438 |
News Archive
Biostar Pharmaceuticals, Inc., a PRC based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial results of the third quarter ended September 30, 2013.
MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners.
A new study conducted by researchers from Tulane University finds reducing target systolic blood pressure below current recommendations significantly reduces the risk of cardiovascular disease and preventable death.
Discovering key elements of immune system T cell biology and applying that knowledge to create a new way to treat cancer has earned Jim Allison, Ph.D., the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua F Phillips, MD 1513 Lakeland Dr., Suite 101, Jackson, MS 39216 Ph: (601) 354-4836 | Joshua F Phillips, MD 1513 Lakeland Dr.,, Suite 101, Jackson, MS 39216 Ph: (601) 354-4836 |
News Archive
Biostar Pharmaceuticals, Inc., a PRC based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial results of the third quarter ended September 30, 2013.
MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners.
A new study conducted by researchers from Tulane University finds reducing target systolic blood pressure below current recommendations significantly reduces the risk of cardiovascular disease and preventable death.
Discovering key elements of immune system T cell biology and applying that knowledge to create a new way to treat cancer has earned Jim Allison, Ph.D., the 2014 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.
› Verified 3 days ago
Mr. Daniel L Venarske, M.D Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1513 Lakeland Dr., Suite 101, Jackson, MS 39216 Phone: 601-354-4836 Fax: 601-354-2619 | |
Dr. Sheryll Angela Vincent, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5440 Watkins Dr, Ste A, Jackson, MS 39206 Phone: 601-981-3636 Fax: 601-982-5335 | |
Dr. Claire Brabec Rosenblatt, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1513 Lakeland Dr, Suite 101, Jackson, MS 39216 Phone: 601-354-4836 Fax: 601-354-2619 | |
Cara T Stevens, FNP Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-2005 | |
Dexter W Walcott, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1513 Lakeland Dr., Suite 101, Jackson, MS 39216 Phone: 601-354-4836 Fax: 601-354-2619 | |
Dr. Stephen F Kemp, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 878 Lakeland Dr, Lb-building, Jackson, MS 39216 Phone: 601-815-1078 Fax: 601-984-6994 |